Yifan Pharmaceutical (002019.SZ) Earnings Analysis

Yifan Pharmaceutical (002019.SZ) has no confirmed upcoming earnings date. Trailing P/E 35.47.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 002019.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 002019.SZ. This page updates as the calendar is published.

002019.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-240.0878 CNYn/an/an/a
2026-04-230.0117 CNYn/an/an/a
2025-10-300.06917 CNYn/an/an/a
2025-04-300.1477 CNYn/an/an/a
2025-04-280.01624 CNYn/an/an/a
2024-08-140.08755 CNYn/an/an/a

002019.SZ valuation and analyst view

Trailing P/E35.47
Trailing EPS0.29233 CNY
Price / book1.40
Dividend yield0.98%
Market cap12.32B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Yifan Pharmaceutical (002019.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 002019.SZ. This page updates as the calendar is published.

Did 002019.SZ beat earnings last quarter?

Consensus estimate data was not available for 002019.SZ's 2026-04-24 report.

What is 002019.SZ's current P/E ratio and EPS?

002019.SZ trades at a trailing P/E of 35.47 on trailing EPS of 0.29233460760094976 CNY.

What do analysts rate 002019.SZ?

002019.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.